Navigation Links
Bio-AMD, Inc.; Legal Action Settled
Date:12/8/2011

LONDON, Dec. 8, 2011 /PRNewswire/ -- Bio-AMD, Inc. ("Bio-AMD" or the "Company) (OTCBB: BIAD) today announces settlement of a claim against its former legal counsel.

The Company is pleased to have satisfactorily settled its claim prior to a timetabled court hearing in 2012 which would otherwise have resulted in further cost, distraction and risk to its business. The Company now looks forward to further progressing its core medical diagnostic device operations.

About Bio-AMD, Inc.

Bio-AMD has two majority owned UK subsidiaries: Bio-AMD Limited, a technology developer for medical diagnostic devices; and the WDX Organisation Ltd, the owner of the Wocu™, a global currency data reference source for application in financial markets. (www.wocu.com).

To find out more about Bio-AMD (OTCBB: BIAD), visit our websites at www.bioamd.com.

Forward-Looking Statements

Statements in this news release that are not statements of historical fact are forward-looking statements, which are subject to certain risks and uncertainties.  Forward-looking statements can often be identified by words such as "expects," "intends," "plans," "may," "could," "should," "anticipates," "likely," "believes" and words of similar import.  Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management.  Actual results may differ materially from those expressed or implied by forward-looking statements due to a variety of factors that may or may not be foreseeable or within the reasonable control of the Company.  Readers are cautioned not to place undue reliance on such forward-looking statements.  Additional information on risks and other factors that may affect the business and financial results of the Company can be found in filings of the Company with the U.S. Securities and Exchange Commission, including without limitation under the caption "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2010 filed on March 23, 2011.  Except as otherwise required by law, the Company disclaims any obligations or undertaking to publicly release any updates or revisions to any forward-looking statement contained in this news release to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

CONTACT:  Bio-AMD, Inc.
Tom Barr, CEO
+44 (0)8445 861 910


'/>"/>
SOURCE Bio-AMD, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Smith & Nephew Inc. Acquires Privately-Held TENET Medical Engineering, Inc.; Premier Provider of Surgical Patient Positioning Equipment
2. Vista Partners Initiates Coverage on ADVENTRX Pharmaceuticals, Inc.; Target Price $7.50
3. Vista Partners Updates Coverage on Opexa Therapeutics, Inc.; Maintains Target Price of $6.50
4. Vista Partners Updates Coverage on Pro-Pharmaceuticals, Inc.; Raises Target Price to $3.22
5. Vista Partners Updates Coverage on Pro-Pharmaceuticals, Inc.; Maintains Target Price of $2.10
6. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
7. Alabama Stop-Sale System Blocks Illegal Sales & Allows Legal Ones
8. PharmAthene Submits Legal Brief in Response to SIGA Technologies Motion for Reargument
9. NADDI Lauds Ohio Bill Introduction: Real-Time, Stop-Sale System Blocks Illegal Sales
10. CMUs Nicolas Christin Finds Web Hackers Profiting From Illegal Online Pharmacies
11. Avanir Pharmaceuticals Announces Appointment of Elona Kogan, Esq. as Vice President of Legal Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2017)...  Novavax, Inc., (Nasdaq: NVAX ) today announced ... of its RSV F protein recombinant nanoparticle vaccine candidate (RSV ... published in the journal Vaccine (the ... scientific conferences). The Company previously announced top line results ... the RSV F Vaccine with the goal of protecting infants ...
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq: ... care, today announced new findings demonstrating positive biochemical outcomes ... System One™. The data will be presented at ... Madrid, Spain . ... Improve Home Dialysis Network in Europe ...
(Date:5/29/2017)...  Cellect Biotechnology Ltd. (NASDAQ: APOP ; TASE: ... functional selection of stem cells, today provided a corporate ... ended March 31 st , 2017. ... first quarter of 2017," said Dr. Shai Yarkoni, Chief ... treatment of the first blood cancer patient in the ...
Breaking Medicine Technology:
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... Breast Cancer Conference from Sept. 18 to 20. , The two-day conference is ... subtype with the goal of improving patients’ lives and eliminating racial breast cancer-related ...
(Date:6/23/2017)... Monica, CA (PRWEB) , ... June 23, 2017 , ... ... as the endorsed amalgam separator supplier for CDA members. As part of the amalgam ... reduced price of $99, saving more than $400 off the retail value. This partnership ...
(Date:6/23/2017)... San Francisco, CA (PRWEB) , ... June 23, 2017 , ... ... Conference on 26th June, 2017 from 9 am to 3 pm to present to ... curriculum. The program is an original curriculum project led by The Health Improvement ...
(Date:6/23/2017)... Gilmer, TX (PRWEB) , ... June 23, 2017 , ... ... consultations to residential and business clients throughout eastern Texas, is announcing the launch of ... , Recent breast cancer statistics in the United States reveal that an estimated ...
(Date:6/22/2017)... Miami, FL (PRWEB) , ... June 22, 2017 , ... ... has received more than $245,000 in grant funding to support its programs focused on ... recently, Branches, Inc. was awarded a grant by the Foundation of $15,000 to support ...
Breaking Medicine News(10 mins):